NEURAGEN 3D Trademark

Trademark Overview

On Thursday, October 6, 2016, a trademark application was filed for NEURAGEN 3D with the United States Patent and Trademark Office. The USPTO has given the NEURAGEN 3D trademark a serial number of 87195169. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Integra LifeSciences Corporation. The NEURAGEN 3D trademark is filed in the Medical Instrument Products category with the following description:

Surgical implants derived from living tissue for the regeneration of neural tissues
neuragen 3d

General Information

Serial Number87195169
Word MarkNEURAGEN 3D
Filing DateThursday, October 6, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements

Disclaimer with Predetermined Text"3D"
Goods and ServicesSurgical implants derived from living tissue for the regeneration of neural tissues
Pseudo MarkNEURAGEN THREE D

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, October 12, 2016
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIntegra LifeSciences Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlainsboro, NJ 08536
Party NameIntegra LifeSciences Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPlainsboro, NJ 08536

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 27, 2019EXTENSION 5 GRANTED
Monday, September 23, 2019EXTENSION 5 FILED
Friday, September 27, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 23, 2019TEAS EXTENSION RECEIVED
Wednesday, April 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 1, 2019EXTENSION 4 GRANTED
Monday, April 1, 2019EXTENSION 4 FILED
Monday, April 1, 2019TEAS EXTENSION RECEIVED
Friday, October 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 10, 2018EXTENSION 3 GRANTED
Wednesday, October 10, 2018EXTENSION 3 FILED
Wednesday, October 10, 2018TEAS EXTENSION RECEIVED
Monday, July 23, 2018ASSIGNED TO EXAMINER
Friday, April 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 11, 2018EXTENSION 2 GRANTED
Wednesday, April 11, 2018EXTENSION 2 FILED
Wednesday, April 11, 2018TEAS EXTENSION RECEIVED
Wednesday, October 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 9, 2017EXTENSION 1 GRANTED
Monday, October 9, 2017EXTENSION 1 FILED
Monday, October 9, 2017TEAS EXTENSION RECEIVED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 16, 2017EXAMINER'S AMENDMENT ENTERED
Monday, January 16, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 16, 2017EXAMINERS AMENDMENT E-MAILED
Monday, January 16, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, January 16, 2017ASSIGNED TO EXAMINER
Thursday, October 13, 2016NOTICE OF PSEUDO MARK E-MAILED
Wednesday, October 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 10, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

neuragen regeneration neural tissues tissue living implants derived from surgical